FDA
approval
· 2022-04-29
FDA Approved: TWIRLA — Supplemental Application (Agile Therapeutics, Inc.)
Summary
The FDA approved a supplemental application for TWIRLA (levonorgestrel/ethinyl estradiol) from Agile Therapeutics, Inc., indicating approval of changes under a …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for TWIRLA (LEVONORGESTREL/ETHINYL ESTRADIOL)